BOOT CAMP 2017
Created by Academia; Supported by Industry
Founded in 2005 by Carnegie Mellon University & Wharton School Faculty
Benjamin P. Chen, PhD
Ignatius Transaction Partners, LLC
Dr. Chen is the Managing Partner Ignatius Transaction Partners, a boutique life sciences merchant bank in San Francisco. Ben was most recently the CEO of Los Angeles based ImaginAb, InC. and immediately prior to that he was the CEO of London based Immune Targeting Systems, Inc. Prior to starting his own merchant banking practice, Ben was a Managing Director at Burrill & Company, a San Francisco based global life sciences venture. In his professional career, Dr. Chen has made numerous contributions in assessing technology, transferring discoveries into the clinic, raising venture investment and establishing strategic partnerships among pharmaceutical and biotech companies. Dr. Chen’s merchant banking activities spread out worldwide and include relationships in North America, Europe, Israel, China and the ASEAN countries. Previously Dr. Chen built talented scientific teams in immunology, genomics, virology, gene therapy, vaccine and cell biology at Roche Diagnostics, Sentinel Biosciences (a Roche company), Progenesys, SyStemix (a Novartis company) and Immune Targeting Systems. He played a key role in the IPO of the first biotech start-up that he joined, as well as the acquisition of SyStemix and Sentinel Biosciences by Novartis and Roche Diagnostics, respectively. Dr. Chen studied at the University of Wisconsin-Madison and Stanford University.